T1	Participants 242 249	patient
T2	Participants 358 366	PATIENTS
T3	Participants 461 469	patients
T4	Participants 471 564	Patients were divided into two group, CSII treated group (n=14) and MDI treated group (n=20).
T5	Participants 645 650	group
T6	Participants 1137 1145	patients
T7	Participants 1279 1287	patients
T8	Participants 1445 1453	patients
T9	Participants 1531 1536	group
